 LONDON, Aug 27 (Reuters) - STOCKS NEWS Reuters Results diaryStocks on the move [HOT-RTRS] Real-time Equity News [E] [WEU/EQUITY]07:41GMT 27Aug2008-European shares fall in early trade, banks weighEuropean shares fall in early trade, as weaker banking stocks outweigh the impact of energy shares that gain on a rise in crude prices.The FTSEurofirst 300  index of top European shares is down 0.4 percent at 1,166.89 points, Britain's FTSE 100  falls 0.1 percent, Germany's DAX  down 0.6 percent and France's CAC 40  drops 0.6 percent.Banks are the top weighted sectoral loser on the index, with Natixis  down 5.7 percent, Lloyds TSB  falling 1.2 percent, Dexia  shedding 1.1 percent and Fortis  dropping 1 percent.'Financials have been under a little bit of pressure...I still think the oil price is one of the fundamentals the market is watching at the moment in terms of its effect on inflation and sentiment,' says Henk Potts, equity strategist at Barclays Stockbrokers.Oil rises for a third straight session to near $117 a barrel on growing fears over Tropical Storm Gustav, heading towards oil and natural gas installations in the Gulf of Mexico.For more please double click on [.EU]Reuters Messaging: rm://atul.prakash.reuters.com@reuters.net07:36GMT 27Aug2008-BSkyB jumps as Goldman adds to Conviction BuyShares in British Sky Broadcasting  rise 1.8 percent, topping the FTSE 100 leaders board as Goldman Sachs adds the stock to its Conviction Buy List in a major review of the European Media sector.The broker says it believes BSkyB shares are structurally solid and trade at a significant cyclical discount, while trimming its target price for the stock to 593 pence from 770 pence.Reuters Messaging rm://jon.hopkins.thomsonreuters.com@reuters.net07:30GMT 27Aug2008-Bayer gains on setback for rival drugBayer  shares rise 0.7 percent, outperforming a 0.9 percent fall in the European healthcare sector , as prospects for its blood clot preventer Xarelto are boosted by a setback for a rival product.Bristol-Myers Squibb  and Pfizer  no longer plan to seek marketing approval next year for their apixaban medicine, which failed its primary goal in a late-stage trial.Further clinical trial results with apixaban are still awaited but analysts say the setback will consolidate Xarelto's first-mover advantage. Both drugs work by blocking a protein called Factor Xa.Morgan Stanley analysts say their risk-adjusted Xarelto sales forecast for 2014 of 1.2 billion euros ($1.77 billion) now looks conservative.For more double click on [ID:nN26375896]Reuters Messaging rm://ben.hirschler.reuters.com@reuters.net07:30GMT 27Aug2008-Henkel top DAX gainer after Credit Suisse upgradeShares in German consumer goods group Henkel  rise 3.1 percent to 27.50 euros, topping the DAX  leaderboard, after Credit Suisse upgrades the stock to 'neutral' from 'underperform'.'Less risk, more reward is how we would characterise our change of view,' Credit Suisse says in a note, adding that the Henkel share could be worth up to 40 euros.Reuters Messaging rm://peter.starck.reuters.com@reuters.net07:24GMT 27Aug2008-Natixis hit by rights issue discount talkNatixis  falls sharply in early trade on growing speculation that the bank will announce a 30-40 percent discount price for its previously announced 3.7 billion euro ($5.44 billion) rights issue in coming days.French newspaper La Tribune cited unnamed analysts on Tuesday as saying that Natixis could give a discount of at least between 30-40 percent for its rights issue price.Natixis officials could not be immediately reached for comment on the report.Natixis shares were down 5.5 percent at 5.65 euros by 0715 GMT. The DJ Stoxx European bank sector  was down 0.6 percent.'They desperately need the money so a discount sounds feasible,' said a fund manager who holds Natixis shares, declining to be named.Reuters Messaging rm://sudip.kar-gupta.reuters.com@reuters.net06:14GMT 27Aug2008-Futures point to mixed open; oil eyedEuropean stock index futures point to a mixed open, with higher oil prices set to weigh on the broad market. Futures for the DJ Euro Stoxx50  are flat, for Germany's DAX  down 0.3 percent and for France's CAC  up 0.2 percent.The pan-European FTSEurofirst 300  index rose 0.2 percent on Tuesday.Brewer Heineken  posts results below forecasts. Later in the session, investors will eye U.S. durable goods data at 1230 GMT.Oil rises for a third straight session on growing fears over Tropical Storm Gustav, heading towards oil and natural gas installations in the Gulf of Mexico.For more details, double click on [.EU]Heineken Antofagasta Voestalpine AP Moller Maersk CNP Assurances Scor Randstad Cimpor Cimentos Grifols Baloise G4S Serco Segro Taylor Nelson Sofres Taylor Wimpey Tullow Oil Autogrill No major U.S. companies due to report1230 U.S. new orders1230 U.S. durable goods1600 U.S. midwest manufacturingReuters Messaging rm://sitaraman.shankar.reuters.com@reuters.netKeywords: MARKETS EUROPE STOCKSNEWS tf.TFN-Europe_newsdesk@thomson.com vsCOPYRIGHTCopyright Thomson Financial News Limited 2008. All rights reserved. The copying, republication or redistribution of Thomson Financial News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Financial News.
